Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Sarcoma 1NET 1Gastrointestinal 1Endocrine 1

Conditions

Breast Neoplasms 7Prostatic Neoplasms 4Brain Neoplasms 4Neoplasms 3Neoplasm Metastasis 3Sarcoma 2Multiple Myeloma 2Lung Neoplasms 2Glioma 2Glioblastoma 2Gastrointestinal Neoplasms 2Fatigue 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Weight Loss 1Uterine Cervical Neoplasms 1Thrombocytopenia 1Symptom Management 1Stomach Neoplasms 1Splenomegaly 1Sexual Dysfunction, Physiological 1Sex Cord-Gonadal Stromal Tumors 1Sarcoma, Synovial 1Rectal Neoplasms 1Peritoneal Neoplasms 1Pain 1Ovarian Neoplasms 1Oligodendroglioma 1Neuroendocrine Tumors 1Neoplasms, Germ Cell and Embryonal 1

Interventions

Oxaliplatin 290Capecitabine 206Fluorouracil 181Cisplatin 168Docetaxel 138S 1 (combination) 132Paclitaxel 121Leucovorin 116Irinotecan 106pembrolizumab 103Trastuzumab 71apatinib 56Nivolumab 56sintilimab 45Drug Therapy 43Surgical Procedures, Operative 37Radiotherapy 37Bevacizumab 37Ramucirumab 34titanium silicide 31Hyperthermic Intraperitoneal Chemotherapy 30Epirubicin 30Carboplatin 30tislelizumab 28Cyclophosphamide 27XELOX 24Tegafur 23Folfox protocol 22Albumin-Bound Paclitaxel 22camrelizumab 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Stomach Neoplasms × Quality of Life × Clear all
NCT04077372 2023-01-27

Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers

Stanford University

Phase NA Terminated
12 enrolled
EndocrineGastrointestinalNETSarcoma

Esophageal Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma, Neuroendocrine Tumors, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡